Stock data
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA) reported revenue of US$7.95M and net income of -US$21.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$7.95M | — | -US$22.56M | -US$21.23M | — |
| 2024 | US$3.55M | — | -US$17.25M | -US$14.88M | — |
| 2023 | US$6.00M | — | -US$7.90M | -US$7.99M | — |
| 2022 | US$0.00M | — | -US$9.81M | -US$12.24M | — |
| 2021 | — | — | -US$4.87M | -US$4.89M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.24M | -US$6.64M | — |
| 2026-03-31 | US$0.25M | -US$7.21M | — |
| 2025-12-31 | US$3.96M | -US$5.71M | — |
| 2025-09-30 | US$3.56M | -US$2.12M | — |
| 2025-06-30 | US$0.16M | -US$6.09M | — |
| 2025-03-31 | US$0.26M | -US$7.31M | — |
| 2024-12-31 | US$0.00M | -US$2.92M | — |
| 2024-09-30 | US$0.00M | -US$4.02M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.